TSX-V:EMO • CA29102L4064
| 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 11.03M | 4.14M | 21.93M | 20.98M | 17.36M | |||
| Research and Development | N/A | 9.38M | 16.47M | 9.60M | 1.78M | |||
| Selling, General, and Administrative Expenses | 11.03M | 4.14M | 5.46M | 11.38M | 15.58M | |||
| Operating Income | -11.03M | -4.14M | -21.93M | -20.98M | -17.36M | |||
| Interest Income/Expense | -1.46M | 7.80K | 426.60K | 270.70K | 129.10K | |||
| Other Income/Expense | N/A | N/A | 10.00K | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -12.51M | -4.14M | -21.49M | -20.71M | -17.23M | |||
| Income Tax | 0.00 | -589.30K | N/A | N/A | N/A | |||
| Net Income | -12.51M | -3.55M | -21.49M | -20.71M | -17.23M | |||
| EBITDA | -10.90M | -3.97M | -21.90M | -20.96M | -17.36M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.05 | -0.01 | -0.10 | -0.11 | -0.13 | |||
| Statistics | ||||||||
All data in CAD